Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prognostic Risk Classification for Biochemical Relapse-Free Survival in Oligometastatic Recurrent Prostate Cancer Determined by Choline PET.
Gravis G, Autret A, Guibert-Broudic M, Dubergé T, Zemmour C, Carrier P, Salem N, Badinand D, Cartier L, Gross E, Walz J, Pignot G, Brenot-Rossi I. Gravis G, et al. Among authors: duberge t. Clin Genitourin Cancer. 2021 Aug;19(4):346-353. doi: 10.1016/j.clgc.2021.03.004. Epub 2021 Mar 16. Clin Genitourin Cancer. 2021. PMID: 33849812
Patterns of practice of androgen deprivation therapy combined to radiotherapy in favorable and unfavorable intermediate risk prostate cancer. Results of The PROACT Survey from the French GETUG Radiation Oncology group.
Belkacemi Y, Latorzeff I, Hasbini A, Coraggio G, Pasquier D, Toledano A, Hennequin C, Bossi A, Chapet O, Crehange G, Guerif S, Duberge T, Allouache N, Clavere P, Gross E, Supiot S, Azria D, Bolla M, Sargos P. Belkacemi Y, et al. Among authors: duberge t. Cancer Radiother. 2020 Dec;24(8):892-897. doi: 10.1016/j.canrad.2020.03.014. Epub 2020 Nov 2. Cancer Radiother. 2020. PMID: 33144063 Review.
[Indications and outlooks of radiohormonal therapy of high-risk prostate cancers].
Latorzeff I, Sargos P, Créhange G, Belkacémi Y, Azria D, Hasbini A, Dubergé T, Toledano A, Graff-Cailleaud P, Chapet O, Hennequin C, de Crevoisier R, Supiot S, Pasquier D. Latorzeff I, et al. Among authors: duberge t. Cancer Radiother. 2020 Apr;24(2):143-152. doi: 10.1016/j.canrad.2019.06.018. Epub 2020 Feb 11. Cancer Radiother. 2020. PMID: 32057646 Review. French.
[Stage 1 testicular seminoma].
Gross E, Champetier C, Pointreau Y, Zaccariotto A, Dubergé T, Chauvet B. Gross E, et al. Among authors: duberge t. Cancer Radiother. 2010 Nov;14 Suppl 1:S182-8. doi: 10.1016/S1278-3218(10)70022-6. Cancer Radiother. 2010. PMID: 21129662 French.
[Normal tissue tolerance to external beam radiation therapy: testicles].
Champetier C, Gross E, Pointreau Y, Zaccariotto A, Dubergé T, Guerder C, Ortholan C, Chauvet B. Champetier C, et al. Among authors: duberge t. Cancer Radiother. 2010 Jul;14(4-5):376-8. doi: 10.1016/j.canrad.2010.01.010. Epub 2010 Apr 24. Cancer Radiother. 2010. PMID: 20418148 French.
[Normal tissue tolerance to external beam radiation therapy: ovaries].
Gross E, Champetier C, Pointreau Y, Zaccariotto A, Dubergé T, Guerder C, Ortholan C, Chauvet B. Gross E, et al. Among authors: duberge t. Cancer Radiother. 2010 Jul;14(4-5):373-5. doi: 10.1016/j.canrad.2010.01.011. Epub 2010 Apr 28. Cancer Radiother. 2010. PMID: 20430663 French.
Adjuvant radiotherapy for extremity and trunk wall atypical lipomatous tumor/well-differentiated LPS (ALT/WD-LPS): a French Sarcoma Group (GSF-GETO) study.
Cassier PA, Kantor G, Bonvalot S, Lavergne E, Stoeckle E, Le Péchoux C, Meeus P, Sunyach MP, Vaz G, Coindre JM, Linassier C, Labib A, Delcambre C, Bay JO, Leyvraz S, Dubergé T, Lagrange JL, Duret A, Blay JY. Cassier PA, et al. Among authors: duberge t. Ann Oncol. 2014 Sep;25(9):1854-1860. doi: 10.1093/annonc/mdu202. Epub 2014 Jun 8. Ann Oncol. 2014. PMID: 24914041 Free article.
Radiation induced gastroparesis-case report and literature review.
Annede P, Prieux-Klotz C, Dubergé T, Chargari C, Gisserot O, de Jaureguiberry JP. Annede P, et al. Among authors: duberge t. J Gastrointest Oncol. 2017 Aug;8(4):E52-E55. doi: 10.21037/jgo.2017.04.06. J Gastrointest Oncol. 2017. PMID: 28890828 Free PMC article.